Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer

Recently, immunotherapy targeting tumor-infiltrating lymphocytes (TILs) has emerged as a critical and promising treatment in several types of cancer. However, not all cancer types have been tested in immunotherapeutic trials, and different patients and cancer types may have unpredictable clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ming, Li, Yi-Ming, Liu, Zhen-Yu, Zhang, Xin, Zhou, Yinghui, Jiang, Jian-Li, Zhu, Ping, Yang, Xiang-Min, Tang, Juan, Chen, Zhi-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771864/
https://www.ncbi.nlm.nih.gov/pubmed/35069521
http://dx.doi.org/10.3389/fimmu.2021.731329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771864/
https://www.ncbi.nlm.nih.gov/pubmed/35069521
http://dx.doi.org/10.3389/fimmu.2021.731329

Ejemplares similares